Computational Analysis of crRNA to Regulate hsa-miR-301b-3p and hsa-miR-21 related to metastasis and cell proliferation in acute myeloid leukemia (AML) using CRISPR/C2c2

Author:

Moeini Omid1,Gholamzad Amir1,Khatibi Mahsa2,Nourikhani Mohammadmatin1,Hosseini SeyedArmit1,Rahmani Amirali1,Aliyarzadeh Arshia1,Gholamzad Mehrdad1

Affiliation:

1. Tehran Medical Sciences, Islamic Azad University

2. Imam Khomeini Hospital

Abstract

Abstract Background Myeloid or lymphoid progenitors in the bone marrow can develop into leukemia, which is clonal cancer. Acute myeloid leukemia (AML) developed as a result of somatic mutations in the precursor cells of the myeloid lineage along with transcriptome dysregulation of bone marrow infiltration, which resulted in the generation of immature myeloid cells (blasts) and disruption of normal hematopoiesis. Current research has demonstrated the metastasis potential of a certain subset of microRNAs. As a result, miRNA downregulation at the transcriptional level can reduce the possibility of metastasis. The purpose of this work is to analyze miRNA precursor targeting utilizing the CRISPR-C2c2 (Cas13a) method. Results crRNAs designed for miR-301b and miR-21 has a very high structural similarity with binding energy to the state observed in the normal condition. Conclusion Sequence-based evaluation of crRNAs intended for RNA-level editing is insufficient; simulation and molecular docking investigations should also be carried out for improved accuracy.

Publisher

Research Square Platform LLC

Reference31 articles.

1. Acute myeloid leukaemia;Short NJ;The Lancet,2018

2. Acute Myeloid Leukemia;Dohner H;N Engl J Med,2015

3. Gholamzad A, Daryoushi G, Khatibi M, Khonche S, Ahmadpour A, Malek M, Mehrkhah A, Re-zazadeh H, Sichani AB, Jafari P. A Comprehensive Review in Novel Therapeutics in Acute Leukemia. IJCMCR 2022; 19 (5), 3:46–46.

4. The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients;Klastersky J;J Clin Oncol,2000

5. Role of MicroRNA-30c in cancer progression;Han W;J Cancer,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3